CAC
CNGLW

Cowen and Company’s Canna-Global Acquisition Corp Warrant CNGLW Stock Holding History

Cowen and Company’s Portfolio CNGLW Stock Details CNGLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-457,959
Closed -$4.81K – 782
2024
Q2 		$4.81K Hold
457,959
– – ﹤0.01% 525
2024
Q1 		$9.62K Buy
457,959
+7,800
+2% +$144 ﹤0.01% 513
2023
Q4 		$8.46K Buy
450,159
+336,523
+296% +$4.31K ﹤0.01% 414
2023
Q3 		$2K Hold
113,636
– – ﹤0.01% 595
2023
Q2 		$2.65K Buy
113,636
+8,347
+8% +$250 ﹤0.01% 512
2023
Q1 		$3.13K Sell
105,289
-100
-0.1% -$3 ﹤0.01% 500
2022
Q4 		$2.1K Sell
105,389
-94,600
-47% -$2.27K ﹤0.01% 569
2022
Q3 		$5K Hold
199,989
– – ﹤0.01% 507
2022
Q2 		$16K Sell
199,989
-225,535
-53% -$24.7K ﹤0.01% 431
2022
Q1 		$60K Buy
+425,524
New +$73.3K 0.01% 314

Other funds holding CNGLW

EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

Cowen and Company's CNGLW Position: Q3 2024 in Review

Cowen and Company sold out of Canna-Global Acquisition Corp Warrant (CNGLW) in Q3 2024, closing a stake of 457,959 shares — an estimated $4.81K sold.

Cowen and Company first reported a position in CNGLW in Q1 2022 and held it in 10 quarters. The position peaked at $60K in Q1 2022. 6 funds tracked by Wall St. Rank hold CNGLW as of Q3 2024.

  • Cowen and Company reported no remaining Canna-Global Acquisition Corp Warrant position as of Q3 2024 after selling out during the quarter.
  • Cowen and Company sold 457,959 Canna-Global Acquisition Corp Warrant shares in Q3 2024, an estimated $4.81K.
  • Cowen and Company first reported a position in Canna-Global Acquisition Corp Warrant in Q1 2022 and held it in 10 quarters.
  • Cowen and Company's Canna-Global Acquisition Corp Warrant position peaked at $60K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Canna-Global Acquisition Corp Warrant as of Q3 2024.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.